Prometheon Pharma, LLC

Breakthrough product, $20B/year initial market, and expert team, with a business model providing revenue prior to product launch.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Gainesville, FL, US
  • Currency USD
  • Founded May 2011
  • Employees 4
  • Website prometheonpharma.com

Company Summary

Featured on CNBC: www.bit.ly/ppcnbc

Patented platform technology, initial $15B/yr market. De-risked partnership model that allows big pharma to test our technology for $100k with virtually no risk to them and high margins for us. We are close to closing the first such deal with a global company.

We have delivered insulin, IGF-1 for hair regrowth, and hGH. We are outlicensing/selling the hair growth product to fund internal development in 2015.

Team

  • Devon Grimme

  • Stephen Hsu
    CEO/CSO/Founder

    Harvard trained clinician/scientist with previously commercialized products.

  • Dr. Hua Yao
    Director, R&D

    20 years academic and industry experience in biotech/biopharm

Advisors

  • Dr. Roger Mazze
    Chairman, Board of Managers
    Unconfirmed

Previous Investors

  • Dr. Frank Silver
    Vice Chair, Board of Managers
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free